Literature DB >> 11269261

Interrupting antiretroviral treatment needs particular care.

W A Sewell, C Mazhude, A Murdin-Geretti, S Jones, P J Easterbrook.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11269261      PMCID： PMC1119804     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

Authors:  M Nijhuis; R Schuurman; D de Jong; J Erickson; E Gustchina; J Albert; P Schipper; S Gulnik; C A Boucher
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

Review 2.  Antiretroviral therapy 2000.

Authors:  R Samuel; B Suh
Journal:  Arch Pharm Res       Date:  2000-10       Impact factor: 4.946

3.  Risks of interrupting drug treatment before surgery.

Authors:  D W Noble; H Kehlet
Journal:  BMJ       Date:  2000-09-23
  3 in total
  1 in total

1.  Interrupting drug therapy in the perioperative period.

Authors:  David W Noble; John Webster
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.